Skip to main content
. 2020 Sep 13;185(1):125–134. doi: 10.1007/s10549-020-05921-x

Table 2.

Best overall response in patients with measurable disease at baseline (n = 118)

Best overall response Patients, n (% [95% CI]) (n = 118)
Objective response 99 (83.9 [77.3–90.5)
 Complete response 11 (9.3 [4.08–14.6])
 Partial response 88 (74.6 [66.7–82.4])
 Stable disease 16 (13.6 [7.38–19.74])
 Progressive disease 3 (2.5 [0.00–5.38])

CI confidence interval